Preoperative chemotherapy for bladder cancer: A standard waits to be optimally deployed
Antineoplastic Combined Chemotherapy Protocols
Urinary Bladder Neoplasms
A retrospective study of neoadjuvant gemcitabine plus cisplatin in the current issue of Cancer highlights the activity of this regimen and its low frequency of employment. Directions for the further development of neoadjuvant therapy for bladder cancer are discussed. Copyright © 2011 American Cancer Society.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency